XML 104 R86.htm IDEA: XBRL DOCUMENT
v3.24.0.1

PURIFIED CORTROPHIN GEL PRE-LAUNCH CHARGES (Details) - USD ($) $ in Thousands | 12 Months Ended
--- | ---
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021
Purified Cortrophin Gel pre-launch charges | $ 0 | $ 0 | $ 780
Selling, general, and administrative | 161,697 | 124,044 | $ 84,294
Cortrophin Gel |  |  |
Selling, general, and administrative | $ 14,000 | $ 14,000 |

X
- Definition Amount of charges directly related to the Purified Cortrophin Gel pre-launch charges commercialization efforts, including but not limited to sales and marketing expenses. + References No definition available. + Details
Name: | anip_CortrophinPreLaunchCharges
Namespace Prefix: | anip_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 220 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.4) -Publisher FASB -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2 + Details
Name: | us-gaap_SellingGeneralAndAdministrativeExpense
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Details
Name: | srt_ProductOrServiceAxis=anip_CortrophinGelMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |